ID

29121

Descripción

Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast; ODM derived from: https://clinicaltrials.gov/show/NCT00664534

Link

https://clinicaltrials.gov/show/NCT00664534

Palabras clave

Versiones (1)
  1. 26/2/18 26/2/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

26 de febrero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT00664534

Inglés

Eligibility Diabetes Mellitus, Type 2 NCT00664534

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diabetes mellitus, type 2
Descripción

Diabetes Mellitus, Non-Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
have been receiving metformin plus at least one other oral antihyperglycemic medication (oam) (sulfonylurea or thiazolidinedione [tzd]) without insulin, for at least 90 days prior to visit 1
Descripción

Metformin | Oral hypoglycemic Quantity | Sulfonylurea | Thiazolidinediones | Insulin Absent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0025598
UMLS CUI [2,1]
C0359086
UMLS CUI [2,2]
C1265611
UMLS CUI [3]
C0038766
UMLS CUI [4]
C1257987
UMLS CUI [5,1]
C0021641
UMLS CUI [5,2]
C0332197
glycosylated hemoglobin (hba1c) greater than or equal to 7.0% and less than 11.0%
Descripción

Glucohemoglobin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0202054
regularly consume a light breakfast (less than 15% of total daily calorie intake)
Descripción

Breakfast Small Regular | Percentage Calorie intake per day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2698559
UMLS CUI [1,2]
C0700321
UMLS CUI [1,3]
C0205272
UMLS CUI [2,1]
C0439165
UMLS CUI [2,2]
C2095644
capable and willing to follow the protocol
Descripción

Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
give written consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
are taking a tzd whose country label does not allow in combination with insulin
Descripción

Thiazolidinediones | Combination Insulin Illicit

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1257987
UMLS CUI [2,1]
C0205195
UMLS CUI [2,2]
C0021641
UMLS CUI [2,3]
C0332266
are taking any glucose-lowering agents (other than specified in the inclusion criteria above)
Descripción

Hypoglycemic Agents | Exception Pharmaceutical Preparations Inclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020616
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C1512693
have a body mass index greater than 40 kg/m^2
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
have a history of severe hypoglycemia in past 24 weeks
Descripción

Hypoglycemia Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205082
are pregnant or may become pregnant
Descripción

Pregnancy | Pregnancy Possible

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C0332149
women who are breastfeeding
Descripción

Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147
have significant cardiac disease
Descripción

Heart Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018799
have significant renal or liver disease
Descripción

Kidney Disease | Liver disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0022658
UMLS CUI [2]
C0023895
undergoing therapy for a malignancy
Descripción

Cancer treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0920425
contraindications to study medications
Descripción

Medical contraindication Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
have an irregular sleep/wake cycle
Descripción

Sleep-wake cycle disturbance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1833362
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00664534

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
diabetes mellitus, type 2
boolean
C0011860 (UMLS CUI [1])
Metformin | Oral hypoglycemic Quantity | Sulfonylurea | Thiazolidinediones | Insulin Absent
Item
have been receiving metformin plus at least one other oral antihyperglycemic medication (oam) (sulfonylurea or thiazolidinedione [tzd]) without insulin, for at least 90 days prior to visit 1
boolean
C0025598 (UMLS CUI [1])
C0359086 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0038766 (UMLS CUI [3])
C1257987 (UMLS CUI [4])
C0021641 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
Glucohemoglobin measurement
Item
glycosylated hemoglobin (hba1c) greater than or equal to 7.0% and less than 11.0%
boolean
C0202054 (UMLS CUI [1])
Breakfast Small Regular | Percentage Calorie intake per day
Item
regularly consume a light breakfast (less than 15% of total daily calorie intake)
boolean
C2698559 (UMLS CUI [1,1])
C0700321 (UMLS CUI [1,2])
C0205272 (UMLS CUI [1,3])
C0439165 (UMLS CUI [2,1])
C2095644 (UMLS CUI [2,2])
Protocol Compliance
Item
capable and willing to follow the protocol
boolean
C0525058 (UMLS CUI [1])
Informed Consent
Item
give written consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Thiazolidinediones | Combination Insulin Illicit
Item
are taking a tzd whose country label does not allow in combination with insulin
boolean
C1257987 (UMLS CUI [1])
C0205195 (UMLS CUI [2,1])
C0021641 (UMLS CUI [2,2])
C0332266 (UMLS CUI [2,3])
Hypoglycemic Agents | Exception Pharmaceutical Preparations Inclusion criteria
Item
are taking any glucose-lowering agents (other than specified in the inclusion criteria above)
boolean
C0020616 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C1512693 (UMLS CUI [2,3])
Body mass index
Item
have a body mass index greater than 40 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Hypoglycemia Severe
Item
have a history of severe hypoglycemia in past 24 weeks
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Pregnancy | Pregnancy Possible
Item
are pregnant or may become pregnant
boolean
C0032961 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C0332149 (UMLS CUI [2,2])
Breast Feeding
Item
women who are breastfeeding
boolean
C0006147 (UMLS CUI [1])
Heart Diseases
Item
have significant cardiac disease
boolean
C0018799 (UMLS CUI [1])
Kidney Disease | Liver disease
Item
have significant renal or liver disease
boolean
C0022658 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
Cancer treatment
Item
undergoing therapy for a malignancy
boolean
C0920425 (UMLS CUI [1])
Medical contraindication Investigational New Drugs
Item
contraindications to study medications
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Sleep-wake cycle disturbance
Item
have an irregular sleep/wake cycle
boolean
C1833362 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial